Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00432809 · ClinicalTrials.gov registry record · NA

Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 Diabetes

A NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT00432809 is a NA study of Obesity and Diabetes Mellitus, Type 2 that has completed, run by The Cleveland Clinic. The registered enrollment target is 150 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00432809, a NA study of Obesity and Diabetes Mellitus, Type 2, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The aim of the study is to compare the relative clinical outcomes between advanced medical therapy alone or advanced medical therapy combined with bariatric surgery \[either Roux-en-Y gastric bypass (RYGBP) or laparoscopic sleeve gastrectomy\] in patients with type 2 diabetes and a body mass index (BMI) between 27 and 43 kg/m2. The study will examine the short and long term effects of each intervention on biochemical resolution of diabetes, diabetic complications, and end-organ damage.

Interventions

  • PROCEDURE Sleeve Gastrectomy
  • PROCEDURE Gastric bypass

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2007-02
Est. Completion 2016-09
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT00432809

The ClinicalTrials.gov registry entry for NCT00432809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Sleeve Gastrectomy is the first listed.

NCT00432809 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00432809 about?

NCT00432809 is a clinical study titled "Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 Diabetes". The aim of the study is to compare the relative clinical outcomes between advanced medical therapy alone or advanced medical therapy combined with bariatric surgery \[either Roux-en-Y gastric bypass (RYGBP) or laparoscopic sleeve gastrectomy\] in patients with type 2 diabetes and a body mass index (...

What is the current status of trial NCT00432809?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2007-02. Estimated completion is 2016-09.

What conditions does trial NCT00432809 study?

This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT00432809?

The interventions under investigation include: Sleeve Gastrectomy (PROCEDURE), Gastric bypass (PROCEDURE).

Who is sponsoring clinical trial NCT00432809?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00432809 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.